Endocrine Society’s New Scientific Statement Identifies Research Gaps in Pediatric, LGBTQIA Care
In a new Scientific Statement released today, the Endocrine Society identifies areas for future endocrine research to reduce health disparities in pediatric and sexual and gender minoritized populations. This Scientific Statement expands the Society’s 2012 statement by focusing on endocrine disease disparities in the pediatric and sexual and gender minoritized populations. These include pediatric and...
A Physician’s Physician – Remembering Robert G. Dluhy,1937-2022
Endocrine Society Endorses Bipartisan Bill to Address Insulin Affordability
The Endocrine Society today endorsed the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act of 2023, a bipartisan insulin affordability bill. Introduced by Sens. Jeanne Shaheen (D-NH) and Susan Collins (R-ME), this legislation would cap out-of-pocket insulin costs for those with private insurance, ensure patients can share in insulin rebates and discounts,...
Endocrinology is a field with strong female representation today, with women making up 70% of all endocrinologists in training (Pelley et al., 2016). However, for much of the 20th century, endocrinology, like most areas of medicine, was male dominated and exclusionary toward women seeking to enter the discipline. Among the few women who successfully broke...
Endocrine Society Supports EPA Rule Regulating “Forever Chemicals” in Drinking Water
The Endocrine Society supports a new U.S. Environmental Protection Agency (EPA) rule which includes provisions to regulate several per- and polyfluoroalkyl substances (PFAS)—including PFOA and PFOS—found in our drinking water. The proposed regulation sets an aggressive limit for these PFAS and their mixtures and acknowledges effects at extremely low levels by proposing a health based...